Biological evaluation of new TEM1 targeting recombinant antibodies for radioimmunotherapy: In vitro, in vivo and in silico studies-Reference-Cited by-同舟云学术

Biological evaluation of new TEM1 targeting recombinant antibodies for radioimmunotherapy: In vitro, in vivo and in silico studies

Published:2021-01 Issue: Volume:158 Page:233-244
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

D'Onofrio Alice,Gano Lurdes,Melo Rita,Mendes Filipa,Oliveira Maria Cristina,Denoël Thibaut,Schaefer Niklaus,Viertl David,Fierle Julie,Coukos George,Dunn Steven,Prior John O.,Paulo António

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference60 articles.

1. Cancer radioimmunotherapy;Sharkey;Immunotherapy,2011

2. Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges;Martins;Expert Opin. Drug Deliv.,2018

3. Radioimmunotherapy of human tumours;Larson;Nat. Rev. Cancer,2015

4. Safety and efficacy of anti-PD-1 monoclonal antibodies in patients with relapsed or refractory lymphoma: a meta-analysis of prospective clinic trails;Zhou;Front. Pharmacol.,2019

5. Novel methods to improve the efficiency of radioimmunotherapy for non-hodgkin lymphoma;Eskian;Int. Rev. Immunol.,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches;Theranostics;2024

2. Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety;Cancers;2021-11-25

3. A Novel Treatment for Ewing’s Sarcoma: Chimeric Antigen Receptor-T Cell Therapy;Frontiers in Immunology;2021-09-10

4. Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [177Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model;Pharmaceutics;2021-01-13